Susanna High
2020
In 2020, Susanna High earned a total compensation of $3.7M as Chief Operating Officer at Dyne Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $73,336 |
---|---|
Option Awards | $2,646,267 |
Salary | $167,778 |
Stock Awards | $858,106 |
Other | $418 |
Total | $3,745,905 |
High received $2.6M in option awards, accounting for 71% of the total pay in 2020.
High also received $73.3K in non-equity incentive plan, $167.8K in salary, $858.1K in stock awards and $418 in other compensation.
Rankings
In 2020, Susanna High's compensation ranked 3,085th out of 13,090 executives tracked by ExecPay. In other words, High earned more than 76.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,085 | 76th |
Manufacturing | 1,202 | 79th |
Chemicals And Allied Products | 458 | 80th |
Drugs | 396 | 80th |
Pharmaceutical Preparations | 295 | 80th |
High's colleagues
We found two more compensation records of executives who worked with Susanna High at Dyne Therapeutics in 2020.
News
Dyne Therapeutics CEO Josh Brumm's 2023 pay jumps 38% to $6M
April 5, 2024
Dyne Therapeutics CEO Joshua Brumm's 2022 pay rises 6% to $4.3M
April 7, 2023
Dyne Therapeutics CEO Joshua Brumm's 2021 pay falls 66% to $4.1M
April 22, 2022
Dyne Therapeutics CEO Joshua Brumm's 2020 pay jumps 981% to $12M
April 14, 2021